EyePoint (EYPT) Raw Materials (2018 - 2026)

EyePoint (EYPT) reported Raw Materials of $1.2 million for Q1 2026, down 34.86% on a YoY basis from $1.8 million in Q1 2025, and down 5.13% sequentially from $1.2 million in Q4 2025.

EyePoint (EYPT) Raw Materials (2018 - 2026) Analysis & Trends

EyePoint (EYPT) has 9 years of Raw Materials data on file, last reported at $1.2 million in Q1 2026.

  • For the quarter ending Q1 2026, Raw Materials fell 34.86% year-over-year to $1.2 million; the trailing twelve-month figure through Mar 2026 stood at $1.2 million (down 34.86% YoY), and the FY2025 full-year result was $1.2 million, down 25.83% from the prior year.
  • Raw Materials declined to $1.2 million in Q1 2026, from $1.2 million in the prior quarter.
  • In the past five years, Raw Materials ranged from a high of $1.9 million in Q2 2022 to a low of $1.1 million in Q2 2023.
  • A 5-year average of $1.5 million and a median of $1.5 million in 2024 frame the typical range for Raw Materials.
  • Across the five-year window, Raw Materials plunged 48.29% in 2022 and jumped 30.58% in 2024, its largest moves.
  • Tracing EYPT's Raw Materials over 5 years: stood at $1.4 million in 2022, then slipped by 7.59% to $1.3 million in 2023, then climbed by 27.17% to $1.7 million in 2024, then declined by 25.83% to $1.2 million in 2025, then declined by 5.13% to $1.2 million in 2026.
  • Business Quant data shows EYPT's Raw Materials at $1.2 million in Q1 2026, $1.2 million in Q4 2025, and $1.6 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 EyePoint 358.61 Mn 136.07 Mn 168,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 1.17 Mn
Dec 31, 2025 1.23 Mn
Sep 30, 2025 1.61 Mn
Jun 30, 2025 1.68 Mn
Mar 31, 2025 1.79 Mn
Dec 31, 2024 1.66 Mn
Sep 30, 2024 1.50 Mn
Jun 30, 2024 1.49 Mn
Mar 31, 2024 1.45 Mn
Dec 31, 2023 1.30 Mn
Sep 30, 2023 1.27 Mn
Jun 30, 2023 1.14 Mn
Mar 31, 2023 1.27 Mn
Dec 31, 2022 1.41 Mn
Sep 30, 2022 1.70 Mn
Jun 30, 2022 1.95 Mn
Mar 31, 2022 1.63 Mn
Dec 31, 2021 2.73 Mn
Sep 30, 2021 2.79 Mn
Jun 30, 2021 3.14 Mn